Overcoming challenges of treating extensively drug-resistant Acinetobacter baumannii bacteraemic urinary tract infection

Int J Antimicrob Agents. 2018 Oct;52(4):521-522. doi: 10.1016/j.ijantimicag.2018.07.016. Epub 2018 Aug 4.

Authors

Leyland Chuang¹, Lasantha Ratnayake²

Affiliations

¹ Department of Medicine, Ng Teng Fong General Hospital, National University Health System, 1 Jurong East Street 21, Singapore 609606. Electronic address: [email protected].
² Department of Laboratory Medicine, Ng Teng Fong General Hospital, National University Health System, Singapore.

PMID: 30081140
DOI: 10.1016/j.ijantimicag.2018.07.016

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Acinetobacter Infections / drug therapy*
Acinetobacter Infections / microbiology
Acinetobacter Infections / pathology
Acinetobacter baumannii / drug effects*
Acinetobacter baumannii / isolation & purification
Acute Kidney Injury / chemically induced
Acute Kidney Injury / pathology
Aged
Anti-Bacterial Agents / adverse effects
Anti-Bacterial Agents / pharmacology
Anti-Bacterial Agents / therapeutic use*
Bacteremia / drug therapy*
Bacteremia / microbiology
Bacteremia / pathology
Drug Resistance, Multiple, Bacterial*
Humans
Male
Treatment Outcome
Urinary Tract Infections / complications*
Urinary Tract Infections / drug therapy*
Urinary Tract Infections / microbiology
Urinary Tract Infections / pathology

Substances

Anti-Bacterial Agents